Waters Stock Price, News & Analysis (NYSE:WAT)

$228.70
0.00 (0.00 %)
(As of 09/22/2019 12:30 PM ET)
Today's Range
$228.28
Now: $228.70
$231.67
50-Day Range
$201.66
MA: $213.53
$232.13
52-Week Range
$167.93
Now: $228.70
$255.21
Volume1.04 million shs
Average Volume492,387 shs
Market Capitalization$15.27 billion
P/E Ratio27.59
Dividend YieldN/A
Beta1.08
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$9.9305 per share
Book Value$20.69 per share

Profitability

Net Income$593.79 million

Miscellaneous

Employees7,200
Market Cap$15.27 billion
Next Earnings Date10/22/2019 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its Board of Directors has initiated a stock repurchase plan on Tuesday, April 24th 2018, which allows the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 18.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its shares are undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its quarterly earnings data on Tuesday, July, 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.11 by $0.03. The medical instruments supplier earned $599.20 million during the quarter, compared to analyst estimates of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. The company's revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.95 EPS. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, October 22nd 2019. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters updated its FY19 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.08.

What price target have analysts set for WAT?

12 brokerages have issued 1-year price targets for Waters' shares. Their predictions range from $177.00 to $260.00. On average, they anticipate Waters' share price to reach $209.7288 in the next twelve months. This suggests that the stock has a possible downside of 8.3%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 5 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

Media stories about WAT stock have trended somewhat negative recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Waters.

Are investors shorting Waters?

Waters saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 4,941,700 shares, an increase of 18.0% from the July 31st total of 4,186,200 shares. Based on an average daily volume of 577,800 shares, the short-interest ratio is currently 8.6 days. Currently, 7.4% of the shares of the company are sold short. View Waters' Current Options Chain.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.40%), BlackRock Inc. (8.03%), BlackRock Inc. (8.03%), Bank of New York Mellon Corp (6.36%), Baillie Gifford & Co. (3.75%) and Janus Henderson Group PLC (2.55%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

Which institutional investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Bank of America Corp DE, Morgan Stanley, Janus Henderson Group PLC, Janus Henderson Group PLC, Pictet Asset Management Ltd., Pictet Asset Management Ltd. and Renaissance Technologies LLC. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, Elizabeth B Rae, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which institutional investors are buying Waters stock?

WAT stock was bought by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Nuveen Asset Management LLC, Invesco Ltd., Wells Fargo & Company MN, Ontario Teachers Pension Plan Board, Schroder Investment Management Group, Impax Asset Management Group plc and First Trust Advisors LP. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $228.70.

How big of a company is Waters?

Waters has a market capitalization of $15.27 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  386 (Vote Outperform)
Underperform Votes:  515 (Vote Underperform)
Total Votes:  901
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel